Management tracks: FDA, Allergan

Patrick Frey will depart as chief of staff in FDA’s Office of New Drugs (OND) on Aug. 24 to become director of global regulatory policy and R&D at Amgen Inc. (NASDAQ:AMGN). Khushboo Sharma becomes OND’s acting chief of staff. Center for Drug Evaluation and Research Director Janet Woodcock made the announcement in a memo to CDER staff.

Allergan plc (NYSE:AGN) hired Charles Hugh-Jones as CMO and SVP. He was CMO at the Pfizer Oncology unit of Pfizer Inc. (NYSE:PFE)...